Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Athletics: Semenya loses appeal against CAS ruling over testosterone regulations

Published 08/09/2020, 18:36
Updated 08/09/2020, 22:32
© Reuters. South African athlete Semenya speaks at a women's conference in Johannesburg

LAUSANNE, Switzerland (Reuters) - Double Olympic 800 metres champion Caster Semenya has lost her appeal to the Swiss Federal Tribunal (SFT) to set aside a 2019 Court of Arbitration (CAS) ruling that female athletes with high natural testosterone levels must take medication to reduce it.

But the South African has indicated that she may continue her battle in the European and domestic courts ahead of the Olympics in Tokyo next year, vowing to "fight for human rights".

Semenya approached the tribunal in May last year after CAS, sport's highest court, ruled that the regulations of the sport's governing body World Athletics were necessary for athletes with differences in sexual development (DSDs) in races ranging from 400 metres to a mile to ensure fair competition.

The tribunal found that subjecting female athletes to drug or surgical interventions as a precondition to compete does not amount to a violation of Swiss public policy.

Testosterone increases muscle mass, strength and haemoglobin, which affects endurance.

Some competitors have said women with higher levels of the hormone have an unfair advantage.

"I am very disappointed by this ruling, but refuse to let World Athletics drug me or stop me from being who I am," Semenya said in the statement on Tuesday.

"Excluding female athletes or endangering our health solely because of our natural abilities puts World Athletics on the wrong side of history.

"I will continue to fight for the human rights of female athletes, both on the track and off the track, until we can all run free the way we were born."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

World Athletics welcomed the ruling, which they said vindicates their stance in creating a level playing field for all athletes.

"Throughout this long battle, World Athletics has always maintained that its regulations are lawful and legitimate, and that they represent a fair, necessary and proportionate means of ensuring the rights of all female athletes to participate on fair and equal terms," the governing body said in a statement.

"We are very pleased that the highest court in Switzerland has now joined with the highest court in sport in endorsing World Athletics' arguments."

But Semenya's lawyer, Greg Nott, suggested this was far from the end of the road for his client.

"This setback will not be the end of Caster’s story," he said. "The international team (of lawyers) is considering the judgment and the options to challenge the findings in European and domestic courts."

Latest comments

He is clearly a man. This cheating must stop
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.